Variable | Category | Study group | P-value | Normalc value | |
---|---|---|---|---|---|
Normotensive group (n = 63) | Preeclampsia group (n = 63) | ||||
Proteinuria n (%) | Positive | 2 (3.2) | 63 (100) |  < 0.001a | Negative |
Negative | 61(96.8) | 0 (0) | |||
Total leukocyte | Cells/µL: Median (IQR) | 7180 (6020—9280) | 6990 (5290 – 9450) | 0.405b | 3200 – 8800 |
Neutrophil | Cells/µL: Median (IQR) | 5090 (3840—6810) | 5150 (3230—7020) | .581b | 1500 – 7000 |
%: Median (IQR) | 68.5 (63.3—73.2) | 67.3 (61.4—79.4) | 0.678b | 40 – 70 | |
Lymphocyte | Cells/µL: Median (IQR) | 1570 (1370 -1890) | 1540 (1110—1890) | 0.156b | 1000 – 3700 |
%: Median (IQR) | 22 (17.8—26.2) | 22.1 (14.6—28.7) | 0.724b | 20 – 50 | |
Monocytes | Cells/µL: Median (IQR) | 530 (410 – 670) | 460 (350—620) | 0.064b | 130 – 700 |
%: Median (IQR) | 7 (5.8—8.4) | 6.7 (5.6—7.6) | 0.32b | 4 – 8 | |
Basophile | Cells/µL: Median (IQR) | 20 (10—20) | 20 (10—20) | 0.823b | 0 – 100 |
%: Median (IQR) | 0.2 (0.1—0.3) | 0.2 (0.1—0.3) | 0.703b | 0 – 2 | |
Eosinophil | Cells/µL: Median (IQR) | 120 (60—270) | 50 (10—200) | 0.002b | 0 – 400 |
%: Median (IQR) | 1.3 (0.8—3.0) | 0.7 (0.2—2.4) | 0.019b | 0 – 6 | |
Eosinophilia n (%) | 3 (4.8) | 0 (0) | 0.001a | - | |
Normal count n (%) | 4 (73.0) | 31 (49.2) | |||
Eosinopenia n (%) | 14 (22.2) | 32 (50.8) | |||
AST | U/L:Median (IQR) | 22 (19–26) | 41 (25–73) |  < 0.001b | 0 – 31 |
ALT | U/L:Median (IQR) | 13 (10–16) | 24 (15–41) |  < 0.001b | 0 – 32 |
Total bilirubin | mg/dL:Median (IQR) | 0.5 (0.37–0.67) | 0.61 (0.44–0.8) | 0.02b | 0.1 – 1.2 |
Albumin | g/dL:Median (IQR) | 3.18 (2.69–3.49) | 3.11 (2.74–3.34) | 0.215b | 3.8–5.1 |
Total protein | g/dL:Median (IQR) | 5.88 (4.68–6.5) | 5.68 (4.59–6.1) | 0.115b | 6.6–8.7 |